All Access

Health Tech Deals

Health Tech Deals Alerts

Alert

Standard

Health Tech Deals Thought Bubble

Thought Bubble

mustard

BFD Expert Voices - Health Tech Deals

BFD Expert Voices

topics

politics-policy

epstein-files

donald-trump

2026-midterm-elections

immigration

behind-the-curtain

race-and-equity

technology

privacy-tech-regulation

automation-and-ai

tiktok-news

big-tech

social-media

cybersecurity

economy

social-security

inflation

tariffs

federal-reserve

jobs

transportation

business

stock-market-news

retail-news

crypto

media

elon-musk

dealmaking

health

rfk-jr

drug-prices

axios-explains-abortion

public-health

world

israel

axios-explains-ukraine

iran

russia

china

energy-climate

nuclear-energy

climate-energy-policy

climate-change

extreme-weather

alternative-energy

electric-vehicles

science

emerging-tech

biomedicine

newsletters

pittsburgh

atlanta

san-diego

charlotte

boulder

washington-dc

kansas-city

dallas

denver

detroit

des-moines

austin

boston

chicago

cleveland

columbus

houston

indianapolis

miami

nashville

new-orleans

nw-arkansas

philadelphia

phoenix

portland

richmond

salt-lake-city

san-antonio

san-francisco

seattle

tampa-bay

twin-cities

raleigh

huntsville

axios-local

axios-pro

axios-live

the-axios-show

Metabolic care startup Twin Health raised $50 million in Series D funding, Jahangir Mohammed tells Axios exclusively.

Why it matters: Mounting research suggests a remote approach can help people with diabetes manage the condition.

Details: Temasek led the round and existing investors Iconiq Growth, Sofina, Peak XV and Helena joined.

Funds will go towards honing Twin's tech and hiring more growth and engineering staff.

The Series D follows Twin Health's $140 million Series C round in 2021.

Mohammed declined to say when he foresees Twin raising again, adding that he hoped to "escape another round."

How it works: Based in Mountain View, Calif., Twin connects its users with a provider and a coach and equips them with a set of Bluetooth-connected sensors including a continuous glucose monitor, heart rate monitoring watch, and blood pressure sensors.

Through its app, Twin users journal symptoms, energy levels, mood, and current medications so the company can recommend personalized changes.

The company also performs three to four blood labs on each user per year to create its so-called "digital twin model" of their metabolic system.

Twin goes at risk with employers and health plans, meaning its customers pay the company when their employees and members get results. 

Be smart: The authors of a study conducted during the COVID pandemic published in the journal Diabetes Technology and Therapeutics concluded that telemedicine-based approaches to diabetes management "have now proven to be the best option and, in many cases, the only option for providing critical health care."

Zoom in: Twin is currently conducting two randomized controlled trials — one in India and one in the U.S. — analyzing whether people using its approach can successfully enter diabetes remission or "reversal," per Mohammed.

The company in September funded and published a study (whose authors included Twin Health employees) in the journal Endocrine Practice suggesting its approach lowered average blood sugar levels in patients with type 2 diabetes and helped manage fatty liver disease linked to metabolic dysfunction. 

The intrigue: Per Mohammed, Twin's core differentiator from its rivals is its focus on disease reversal using physicians and coaches the company employs full time.

What they're saying: "If you want to do truly soulful work, you don't cut corners with contract[ed employees]; it does not work," Mohammed says.

State of play: Virtual diabetes management emerged as a major proof point for telehealth during COVID, and several companies in the sector have succeeded in drawing a mix of early- and late-stage funding even amidst tough market conditions.

Diabetes care provider Ryse Health in March drew $6.5 million in Series A funds.

Digital diabetes care startup 9am.health last spring collected $16 million in Series A capital.

Virtual metabolic care provider Omada Health last winter raised $192 million in a Series E round.

Digital diabetes management company Virta Health in 2021 pulled in nearly $133 million at a $2.1 billion valuation.

Exclusive: Twin Health gets $50M injection for metabolic care

Temasek led the Series D for the Silicon Valley company.

Health tech deals

Metabolic care startup Twin Health raised $50 million in Series D funding, Jahangir Mohammed tells Axios exclusively.Why it matters: Mounting research suggests a remote approach can help people with diabetes manage the condition.

Exclusive: Twin Health gets $50M injection for metabolic care

What to read next